Work

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Medical Oncology

DOI: 10.1007/s12032-010-9682-1

Authors: Ruta D. Rao, Melody A. Cobleigh, Robert Gray, Mark L. Graham, Larry Norton, Silvana Martino, George Thomas Budd, James N. Ingle, William C. Wood

Institutions: Rush University Medical Center, Dana-Farber Cancer Institute, Waverly Hematology Oncology, Memorial Sloan Kettering Cancer Center, Angeles Clinic and Research Institute, Cleveland Clinic, Mayo Clinic, Emory University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Southwest Oncology Group, ECOG Statistical Office Data Management Grant, G1422427855, G220937036, G3521018462, G358241105, Cancer and Leukemia Group B, G42877212, G436504642, CANCER AND LEUKEMIA GROUP B, G4412485521, Community Clinical Oncology Program, North Central Cancer Treatment Group, ECOG Statistical Office, Eastern Cooperative Oncology Group Operations Office, G964706321

OpenAlex ID: W1979805199

FWCI: 0.302

Cites: 39

Cited by: 20

Related to: 10